These genes include SOCS2, APLN, NDRG2, and the five genes found to be dysregulated across all five cancer to normal sample comparisons: VIPR1, CAMK4, CLEC1B, DNASE1L3, and UBE2S. Figure 1b,c presents a complete summary of these results. This evidence concerns the gene APLN and cancer.